Estimating heterogeneous treatment effects for latent subgroups in observational studies
暂无分享,去创建一个
Mi-Ok Kim | Hang J Kim | Bo Lu | Edward J Nehus | Mi-Ok Kim | Hang J Kim | Bo Lu | Eddie Nehus
[1] Paul R. Rosenbaum,et al. Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms , 1993 .
[2] J. M. Taylor,et al. Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.
[3] R. Grenda. Minimizing steroid use in pediatric kidney recipients , 2011, Pediatric transplantation.
[4] I. Lipkovich,et al. Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials , 2017, Statistics in medicine.
[5] R. Elashoff,et al. A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial , 2011, Statistics in medicine.
[6] B. Tönshoff,et al. A Randomized Trial to Assess the Impact of Early Steroid Withdrawal on Growth in Pediatric Renal Transplantation: The TWIST Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] K. Johansen,et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. , 2004, Journal of the American Society of Nephrology : JASN.
[8] Jennifer L. Hill,et al. Bayesian Nonparametric Modeling for Causal Inference , 2011 .
[9] Xiaogang Su,et al. Interaction Trees with Censored Survival Data , 2008, The international journal of biostatistics.
[10] David M Kent,et al. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.
[11] R. Chang,et al. Growth and weight gain of prepubertal children after cardiac transplantation , 2008, Pediatric transplantation.
[12] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[13] D. Rubin,et al. Using Multivariate Matched Sampling and Regression Adjustment to Control Bias in Observational Studies , 1978 .
[14] H. Chipman,et al. BART: Bayesian Additive Regression Trees , 2008, 0806.3286.
[15] A. Israni,et al. A simple tool to predict outcomes after kidney transplant. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] B. Chavers,et al. Pediatric Kidney Transplantation Using a Novel Protocol of Rapid (6-Day) Discontinuation of Prednisone: 2-Year Results , 2009, Transplantation.
[17] D. Rubin. Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.
[18] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.
[19] Bo Lu,et al. Bias associated with using the estimated propensity score as a regression covariate , 2014, Statistics in medicine.
[20] L. Goldstein,et al. Prognostic and predictive factors in early-stage breast cancer. , 2004, The oncologist.
[21] Stephanie T. Lanza,et al. Latent Class Analysis: An Alternative Perspective on Subgroup Analysis in Prevention and Treatment , 2013, Prevention Science.
[22] Lu Tian,et al. A Simple Method for Detecting Interactions between a Treatment and a Large Number of Covariates , 2012, 1212.2995.
[23] A. Italiano,et al. Prognostic or predictive? It's time to get back to definitions! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Mi-Ok Kim,et al. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance—a propensity score-matched study , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] N. Bundred,et al. Prognostic and predictive factors in breast cancer. , 2001, Cancer treatment reviews.
[26] Menggang Yu,et al. Regularized outcome weighted subgroup identification for differential treatment effects , 2015, Biometrics.
[27] J. Mahan,et al. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement , 2006, Pediatric Nephrology.
[28] Xin Qun Wang,et al. Racial disparities in renal transplant outcomes. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] J. Lunceford,et al. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study , 2004, Statistics in medicine.
[30] Min Zhang,et al. Estimating optimal treatment regimes from a classification perspective , 2012, Stat.
[31] J. Goebel,et al. Outcomes of Steroid‐Avoidance Protocols in Pediatric Kidney Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] Gang Li,et al. Latent Subgroup Analysis of a Randomized Clinical Trial through a Semiparametric Accelerated Failure Time Mixture Model , 2013, Biometrics.
[33] W. Loh,et al. A regression tree approach to identifying subgroups with differential treatment effects , 2014, Statistics in medicine.
[34] Daniel F Hayes,et al. Prognostic and predictive factors revisited. , 2005, Breast.
[35] Bo Lu,et al. Estimating the Effect of Premarital Cohabitation on Timing of Marital Disruption , 2012 .
[36] D. Hooper,et al. Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] D A Follmann,et al. A Multivariate Test of Interaction for Use in Clinical Trials , 1999, Biometrics.
[38] Helena Chmura Kraemer,et al. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach , 2013, Statistics in medicine.
[39] P. Rothwell. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.
[40] Minnie M Sarwal,et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1 , 2003, Transplantation.